NCT02907372View on ClinicalTrials.gov

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

163

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Metastatic Castration-resistant Prostate Cancer (CRPCa)

Interventions

OTHER

neuropsychologic evaluation

OTHER

oncogeriatric evaluation

Trial Locations (6)

Unknown

CHU, Amiens

centre François Baclesse, Caen

Institut régional du Cancer de Montpellier (ICM), Montpellier

Chu Rouen, Rouen

Hôpital FOCH, Suresnes

IGR, Villejuif

All Listed Sponsors

collaborator

National Cancer Institute, France

OTHER_GOV

lead

Centre Francois Baclesse

OTHER

NCT02907372 - Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter